The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loffredo, J. T.
Right arrow Articles by Sette, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loffredo, J. T.
Right arrow Articles by Sette, A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2004, 173: 5064-5076.
Copyright © 2004 by The American Association of Immunologists

Identification of Seventeen New Simian Immunodeficiency Virus-Derived CD8+ T Cell Epitopes Restricted by the High Frequency Molecule, Mamu-A*02, and Potential Escape from CTL Recognition1

John T. Loffredo*, John Sidney{dagger}, Christina Wojewoda*, Elizabeth Dodds{ddagger}, Matthew R. Reynolds*,{ddagger}, Gnankang Napoé*, Bianca R. Mothé§, David H. O’Connor*, Nancy A. Wilson*, David I. Watkins*,{ddagger} and Alessandro Sette2,{dagger}

* National Primate Research Center, University of Wisconsin (WPRC), Madison, WI 53715; {dagger} La Jolla Institute for Allergy and Immunology, San Diego, CA 92109; {ddagger} Department of Pathology and Laboratory Medicine, University of Wisconsin Medical School, Madison, WI 53706; and § Department of Biological Sciences, California State University, San Marcos, CA 92096

MHC class I-restricted CD8+ T cells play an important role in controlling HIV and SIV replication. In SIV-infected Indian rhesus macaques (Macaca mulatta), comprehensive CD8+ T cell epitope identification has only been undertaken for two alleles, Mamu-A*01 and Mamu-B*17. As a result, these two molecules account for virtually all known MHC class I-restricted SIV-derived CD8+ T cell epitopes. SIV pathogenesis research and vaccine testing have intensified the demand for epitopes restricted by additional MHC class I alleles due to the shortage of Mamu-A*01+ animals. Mamu-A*02 is a high frequency allele present in over 20% of macaques. In this study, we characterized the peptide binding of Mamu-A*02 using a panel of single amino acid substitution analogues and a library of 497 unrelated peptides. Of 230 SIVmac239 peptides that fit the Mamu-A*02 peptide-binding motif, 75 peptides bound Mamu-A*02 with IC50 values of ≤500 nM. We assessed the antigenicity of these 75 peptides using an IFN-{gamma} ELISPOT assay with freshly isolated PBMC from eight Mamu-A*02+ SIV-infected macaques and identified 17 new epitopes for Mamu-A*02. The synthesis of five Mamu-A*02 tetramers demonstrated the discrepancy between tetramer binding and IFN-{gamma} secretion by SIV-specific CD8+ T cells during chronic SIV infection. Bulk sequencing determined that 2 of the 17 epitopes accumulated amino acid replacements in SIV-infected macaques by the chronic phase of infection, suggestive of CD8+ T cell escape in vivo. This work enhances the use of the SIV-infected macaque model for HIV and increases our understanding of the breadth of CD8+ T cell responses in SIV infection.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. F. Kotturi, I. Scott, T. Wolfe, B. Peters, J. Sidney, H. Cheroutre, M. G. von Herrath, M. J. Buchmeier, H. Grey, and A. Sette
Naive Precursor Frequencies and MHC Binding Rather Than the Degree of Epitope Diversity Shape CD8+ T Cell Immunodominance
J. Immunol., August 1, 2008; 181(3): 2124 - 2133.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. T. Loffredo, A. T. Bean, D. R. Beal, E. J. Leon, G. E. May, S. M. Piaskowski, J. R. Furlott, J. Reed, S. K. Musani, E. G. Rakasz, et al.
Patterns of CD8+ Immunodominance May Influence the Ability of Mamu-B*08-Positive Macaques To Naturally Control Simian Immunodeficiency Virus SIVmac239 Replication
J. Virol., February 15, 2008; 82(4): 1723 - 1738.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
N. J. Maness, L. E. Valentine, G. E. May, J. Reed, S. M. Piaskowski, T. Soma, J. Furlott, E. G. Rakasz, T. C. Friedrich, D. A. Price, et al.
AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape
J. Exp. Med., October 29, 2007; 204(11): 2505 - 2512.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Asquith and A. R. McLean
In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques
PNAS, April 10, 2007; 104(15): 6365 - 6370.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. C. Friedrich, L. E. Valentine, L. J. Yant, E. G. Rakasz, S. M. Piaskowski, J. R. Furlott, K. L. Weisgrau, B. Burwitz, G. E. May, E. J. Leon, et al.
Subdominant CD8+ T-Cell Responses Are Involved in Durable Control of AIDS Virus Replication
J. Virol., April 1, 2007; 81(7): 3465 - 3476.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. T. Loffredo, B. J. Burwitz, E. G. Rakasz, S. P. Spencer, J. J. Stephany, J. P. Giraldo Vela, S. R. Martin, J. Reed, S. M. Piaskowski, J. Furlott, et al.
The Antiviral Efficacy of Simian Immunodeficiency Virus-Specific CD8+ T Cells Is Unrelated to Epitope Specificity and Is Abrogated by Viral Escape
J. Virol., March 15, 2007; 81(6): 2624 - 2634.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Chung, W. Lee, J. T. Loffredo, B. Burwitz, T. C. Friedrich, J. P. Giraldo Vela, G. Napoe, E. G. Rakasz, N. A. Wilson, D. B. Allison, et al.
Not All Cytokine-Producing CD8+ T Cells Suppress Simian Immunodeficiency Virus Replication
J. Virol., February 1, 2007; 81(3): 1517 - 1523.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
D. R. M. Negri, M. Borghi, S. Baroncelli, I. Macchia, V. Buffa, L. Sernicola, P. Leone, F. Titti, and A. Cara
Identification of a cytotoxic T-lymphocyte (CTL) epitope recognized by Gag-specific CTLs in cynomolgus monkeys infected with simian/human immunodeficiency virus.
J. Gen. Virol., November 1, 2006; 87(Pt 11): 3385 - 3392.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. A. Wilson, J. Reed, G. S. Napoe, S. Piaskowski, A. Szymanski, J. Furlott, E. J. Gonzalez, L. J. Yant, N. J. Maness, G. E. May, et al.
Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239.
J. Virol., June 1, 2006; 80(12): 5875 - 5885.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. H. Newberg, K. J. McEvers, D. A. Gorgone, M. A. Lifton, S. H. C. Baumeister, R. S. Veazey, J. E. Schmitz, and N. L. Letvin
Immunodomination in the Evolution of Dominant Epitope-Specific CD8+ T Lymphocyte Responses in Simian Immunodeficiency Virus-Infected Rhesus Monkeys
J. Immunol., January 1, 2006; 176(1): 319 - 328.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. T. Loffredo, J. Sidney, S. Piaskowski, A. Szymanski, J. Furlott, R. Rudersdorf, J. Reed, B. Peters, H. D. Hickman-Miller, W. Bardet, et al.
The High Frequency Indian Rhesus Macaque MHC Class I Molecule, Mamu-B*01, Does Not Appear to Be Involved in CD8+ T Lymphocyte Responses to SIVmac239
J. Immunol., November 1, 2005; 175(9): 5986 - 5997.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. C. Krebs, Z. Jin, R. Rudersdorf, A. L. Hughes, and D. H. O'Connor
Unusually High Frequency MHC Class I Alleles in Mauritian Origin Cynomolgus Macaques
J. Immunol., October 15, 2005; 175(8): 5230 - 5239.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. H. O'Connor, A. B. McDermott, K. C. Krebs, E. J. Dodds, J. E. Miller, E. J. Gonzalez, T. J. Jacoby, L. Yant, H. Piontkivska, R. Pantophlet, et al.
A Dominant Role for CD8+-T-Lymphocyte Selection in Simian Immunodeficiency Virus Sequence Variation
J. Virol., December 15, 2004; 78(24): 14012 - 14022.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.